<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210516051316N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-18</date_registration>
      <primary_sponsor>Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>The effect of valerian and lavender essential oil on coronary heart disease</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of aromatherapy with valerian and lavender essential oil on vital signs, drug use and headache relief due to nitroglycerin infusion in coronary artery disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56476</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, eligible patients will be divided into three groups: lavender, 2. valerian and 3. control group by random sampling with ball and bag tools. Patients are told that the effect of a scent on them is measured, which is not harmful to them.
This process will be performed by one of the ward nurses who is not aware of the research (someone outside the research team). That is, this person numbers the scents and writes the name and number of each scent in an envelope and after completing the analysis to The researcher delivers. Both groups do not know the type of fragrance used and number 1 and 2 are used instead of the name on the fragrance. The researcher and statistical consultant is not aware of this numbering, Blinding description: Both groups did not know the type of fragrance used, and instead of naming the fragrance, numbers 1 and 2 were used by someone outside the research team, and the researcher was not aware of this numbering; Also, the statistical consultant did not know the names of the fragrances and only the analysis was performed with numbers 1 and 2 and the control group. The appearance of the scents and the packaging and the color and shape of their use are quite similar.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Coronary artery disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  1. Lavender"  Patients of the experimental group (lavender group) After complaining of headache, lavender essential oil 1.5% prepared by Kazerun Agro-industrial Company with cotton soaked in 3 drops of it to the collar Inhaled for 30 minutes, vital signs including blood pressure, heart rate, temperature, and blood oxygen saturation before and after the intervention were measured in three groups. The time period (before the intervention and 15, 30 and 60 minutes after the intervention) was measured using the visual pain scale. Intervention 2: Intervention group:  2. Valerian   "Patients of the experimental group (Valerian group) After complaining of headache, Valerian essential oil 1.5% prepared by Kazerun Agro-industrial Company with cotton soaked in 3 drops of it to the collar Inhaled for 30 minutes, vital signs including blood pressure, heart rate, temperature, and blood oxygen saturation before and after the intervention were measured in three groups. The time period (before the intervention and 15, 30 and 60 minutes after the intervention) was measured using the visual pain scale. Intervention 3: "Control group" In the control group, no intervention was performed and only the usual methods of pain control performed in the ward were performed in these patients. Vital signs including blood pressure, heart rate, temperature, blood oxygen saturation before and after the intervention were also measured in three groups. The severity of patients' headache in 4 time periods (before the intervention and 15, 30 and 60 minutes after the intervention) was measured using the visual pain scale.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After conducting the research, a decision is made</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Leili Yekefallah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Nursing, Social Determinants of Health Research Center, School of Nursing &amp; Midwifery, Qazvin University of Medical Sciences, Qazvin, Iran</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3419915315</zip>
        <telephone>+98 28 3333 8034</telephone>
        <email>leili_fallah@yahoo.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Ghapanvari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Bahonar Boulevard - Qazvin University of Medical Sciences, Qazvin, Iran</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3419915315</zip>
        <telephone>+98 28 3333 8034</telephone>
        <email>fatemehghapanvari89@gmail.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>No previous history of nitrate use
no history of allergies
no use of painkillers 6 hours before the intervention
no headache before the intervention
no use of perfume or cologne before or during the intervention
No history of drug addiction according to the patient
no olfactory disorder according to the patient</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Withdrawal from the study
having a headache before the infusion of nitroglycerin
decreased level of consciousness during the study
allergies caused by the essential oils of valerian and lavender or herbal essences during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I25.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Atherosclerotic heart disease of native coronary artery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  1. Lavender"  Patients of the experimental group (lavender group) After complaining of headache, lavender essential oil 1.5% prepared by Kazerun Agro-industrial Company with cotton soaked in 3 drops of it to the collar Inhaled for 30 minutes, vital signs including blood pressure, heart rate, temperature, and blood oxygen saturation before and after the intervention were measured in three groups. The time period (before the intervention and 15, 30 and 60 minutes after the intervention) was measured using the visual pain scale.</i_keyword>
      <i_keyword>Intervention group:  2. Valerian   "Patients of the experimental group (Valerian group) After complaining of headache, Valerian essential oil 1.5% prepared by Kazerun Agro-industrial Company with cotton soaked in 3 drops of it to the collar Inhaled for 30 minutes, vital signs including blood pressure, heart rate, temperature, and blood oxygen saturation before and after the intervention were measured in three groups. The time period (before the intervention and 15, 30 and 60 minutes after the intervention) was measured using the visual pain scale.</i_keyword>
      <i_keyword>"Control group" In the control group, no intervention was performed and only the usual methods of pain control performed in the ward were performed in these patients. Vital signs including blood pressure, heart rate, temperature, blood oxygen saturation before and after the intervention were also measured in three groups. The severity of patients' headache in 4 time periods (before the intervention and 15, 30 and 60 minutes after the intervention) was measured using the visual pain scale.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood pressure. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: manometer.</prim_outcome>
      <prim_outcome>Drug use following the inhalation of fragrance and its effect on headache The need for narcotics changes based on the visual pain scale. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Heart rate monitoring device.</prim_outcome>
      <prim_outcome>Temperature. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Mercury thermometer.</prim_outcome>
      <prim_outcome>Respiratory Rate. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Count the number of breaths per minute based on chest movements while breathing.</prim_outcome>
      <prim_outcome>Percentage of blood oxygen saturation. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: pulse oximetry.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Visual Analogue Scale (VAS ).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Qazvin University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-11-21</approval_date>
        <contact_name>Research Ethics Committee of Qazvin University of Medical Sciences</contact_name>
        <contact_address>Shahid Beheshti Boulevard Qazvin Qazvin Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
